Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Aesthetic treatments can safely improve cancer patients' quality of life with oncologist approval.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Panitumumab can cause excessive ear hair growth.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Cancer treatments often cause skin, nail, and hair problems.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.